期刊文献+

不同剂型即释芬太尼治疗癌症爆发痛的选择与研究进展 被引量:2

Research status of immediate-release fentanyl formulations treating breakthrough cancer pain
下载PDF
导出
摘要 癌症爆发痛的治疗在提高癌症患者生活质量方面极其重要。目前,临床治疗癌症爆发痛的主要药物为即释吗啡类。即释芬太尼类是近年研究较多的新型即释阿片类,目前已开发出不同的剂型。在癌症爆发痛患者的临床治疗中,应根据患者不同的疼痛特点选择适合的药物剂型。本文就目前即释芬太尼的不同剂型从一般特性、药物疗效对比研究、安全性、患者满意度等几个方面作一综述。 Treatment of breakthrough cancer pain is extremely important for improving the quality of life of cancer patients. Currently, immediate release morphine-like drugs is the major clinical treatment of breakthrough cancer pain. Immediate release fentanyl is a new immediate release opioids researched in recent years, and has been developed different formulations. In clinical we should select the appropriate pharmaceutical formulations according to the characteristics of patients with different pain. In this paper, the current different immediate-release fentanyl is reviewed from the general characteristics, comparative study of drug efficacy, security, satisfaction of patient and other aspects.
出处 《西部医学》 2014年第9期1257-1258,F0003,共3页 Medical Journal of West China
关键词 癌症爆发痛 阿片类药物 芬太尼 芬太尼剂型 Breakthrough cancer pain Opioids Fentanyl Fentanyl formulation
  • 相关文献

参考文献22

  • 1Portenoy RK, Bruns D, Shoemaker B,et al. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics [J]. Opioid Mang, 2010,6(2) :97-108.
  • 2宋志刚,庞东生.盐酸羟考酮控释片直肠给药控制癌痛的临床观察[J].西部医学,2011,23(10):1922-1923. 被引量:2
  • 3Novotna S,Valentova K, Frieova J, et al. A Randomized, Place- bo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm)for breakthrough pain in opioid-trea ted patients with cancerl-J/OL]. Clinical therapeutics, 2014,36 (3) :357-367.
  • 4Taylor DR,Webster LR,Chun SY,et al. Impact of breakthrough pain on quality of life in patients with chronic, non-cancer pain: patient perceptions and effect of treatment with oral transmuco- sal fentanyl citrate (OTFC,ACTIQ) [J]. Pain Med,2007,8(3) : 281-288.
  • 5Ashburn MA, Slevin KA, Messina J, et al. The efficacy and safe- ty of fentanyl buccal tablet compared with immediate-release oxycodone for the t'nanagement of breakthrough pain in opioid- tolerant patients with chronic pain [J]. Anesth Analg, 2011,112 (3) :693-702.
  • 6Webster LR,Slevin KA,Narayana A,et al. Fentanyl buccal tab- let compared with immediate-release oxycodone for the manage- ment of breakthrough pain in opioid-tolerant patients with chro- nic cancer and non-cancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evalu- ate patient outcomes [J]. Pain Medicine, 2013, 14 ( 9 ) : 1332- 1345.
  • 7Kosugi T, Hamada S, Takigawa C, et al. A randomized, double- blind, placebo-controlled study of fentanyl buccal tablet for breakthrough pain: efficacy and safety in Japanese cancer pa- tients [J/OL]. PainSymptomManaga, [2013-10-05]. http:// www. ncbi. him. nih. gov/entrez/query.
  • 8Weinstein SM, Messina J, Xie F. Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain: a long-term, open-label safety study [J]. Cancer 2009,115(11) ,2571 2579.
  • 9兰海涛,邓春美.多瑞吉治疗癌性疼痛68例临床观察[J].西部医学,2005,17(2):150-151. 被引量:14
  • 10Vasisht N,Gever LN, Tagarro I, et al. Single-dose pharmacoki netics of fentanyl buceal soluble film [J]. Pain Medicine, 2010,11 (7) : 1017-1023.

二级参考文献7

共引文献14

同被引文献33

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部